Expression proteomics study to determine metallodrug targets and optimal drug combinations
Abstract The emerging technique termed functional identification of target by expression proteomics (FITExP) has been shown to identify the key protein targets of anti-cancer drugs. Here, we use this approach to elucidate the proteins involved in the mechanism of action of two ruthenium(II)-based an...
Saved in:
Main Authors: | Ronald F. S. Lee, Alexey Chernobrovkin, Dorothea Rutishauser, Claire S. Allardyce, David Hacker, Kai Johnsson, Roman A. Zubarev, Paul J. Dyson |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/4de57fb3c86d42eab3c5f8158d0517a9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
by: Alexey L Chernobrovkin, et al.
Published: (2014) -
ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
by: Amir Ata Saei, et al.
Published: (2019) -
Proteome activity landscapes of tumor cell lines determine drug responses
by: Martin Frejno, et al.
Published: (2020) -
Combining LOPIT with differential ultracentrifugation for high-resolution spatial proteomics
by: Aikaterini Geladaki, et al.
Published: (2019) -
Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
by: Pierre Sabatier, et al.
Published: (2021)